AI Ethics, Patient Recruitment, and a New Vision for Clinical Data: Arnaub Chatterjee

When it comes to understanding the application and potential of AI in clinical trials, you’re unlikely to find a greater expert than Arnaub Chatterjee, Datavant’s GM and president, life sciences, ecosystem and public sector.Arnaub has experience working for private companies, the US government, and as a teacher at Harvard Medical School, giving him unparalleled insight into the AI technologies reshaping study design and helping us to draw valuable insights from the vast amounts of data captured by healthcare organizations.Join Arnaub and Medidata CEO Anthony Costello as they take a deep dive into the cutting-edge of clinical data management. They explore Arnaub’s pioneering work in the early days of Medidata’s adoption of AI, how we can ensure that our models are reliable and unbiased, and our collective project to build an environment that leverages patient data between and beyond clinical trials.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow Arnaub: LinkedIn